| 摘要 |
The preparation and use of 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Lactonic and Open ring 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Methyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Ethyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Hexyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate, Ethyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate-6''-acetate and Ethyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate-6',6''-diacetate sophorolipids as antifungal agents. |
